News
Dr. Reddy’s Laboratories Announces the Launch of Cinacalcet Tablets in the U.S. Market
Dr. Reddy’s Laboratories Ltd. announced the launch of Cinacalcet Tablets, a therapeutic equivalent generic version of Sensipar (cinacalcet) Tablets, approved by the U.S. Food and Drug Administration (USFDA).
The Sensipar brand and generic market had U.S. sales of approximately $312...
News
Syntegon goes live at PACK EXPO Connects 2020
Since the in-person PACK EXPO International and Healthcare Packaging EXPO have been cancelled, the process and packaging technology specialist Syntegon is presenting its latest solutions at the virtually-hosted PACK EXPO Connects from November 9 to 13, 2020. In a...
News
Suriname developed a high quality plasma COVID-19 treatment procedure that is more cost efficient than European methods
The Academic Medical Center (AZP) in Paramaribo, Suriname, successfully studied an efficient method to collect COVID-19 antibody-containing plasma from recovered Covid-19 patients to treat critically ill patients. In contrast with prevailing plasma donation strategies, the Academic Medical Center collects...
News
Digital transformation starts with an attitude says pharmaceutical service provider
The key to digital transformation has been indelibly linked to the latest technology. However more often, what we find is that it’s certainly not a case of bolting on a few digital channels to your existing traditional model, and...
Clinical Trials
INOVIO Reports FDA Partial Clinical Hold for Planned Phase 2 / 3 Trial of COVID-19 Vaccine Candidate INO-4800
INOVIO, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, announced that the U.S. FDA has notified the company it has additional questions about the company's...
News
Centus Biotherapeutics Receives European Marketing Authorization for Equidacent, Biosimilar Avastin
Centus Biotherapeutics Ltd., a joint venture between Fujifilm Kyowa Kirin Biologics Co., Ltd. and AstraZeneca, announced that the European Commission (EC) has granted the marketing authorization for Equidacent® (Product Code: FKB238), the company's biosimilar to Avastin® (bevacizumab).
The authorization follows...
Clinical Trials
Genetron, CStone start clinical trial in China to develop CDx for avapritinib
Genetron and its partner CStone Pharmaceuticals have commenced a clinical trial in China, to jointly develop a companion diagnostic (CDx) test for avapritinib.
Discovered by Blueprint Medicines, Avapritinib is a US Food and Drug Administration (FDA) approved kinase inhibitor, to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
